Article

Shining the spotlight on psychogenic ptosis

Author(s):

The rare disorder is often a delayed or misdiagnosed condition, resulting in unnecessary referrals and imaging.

Shining the spotlight on psychogenic ptosis

Investigators focused on identifying the clinical parameters, etiology, psychological, and clinical aspects of psychogenic ptosis.

Tiffany Ho, MD, and colleagues from the John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University in St. Louis, investigated the rare disorder of psychogenic ptosis and suggested that patient reassurance may be the most appropriate path to resolution.

In their retrospective study, they focused on identifying the clinical parameters, etiology, psychological, and clinical aspects of psychogenic ptosis.

The investigators reviewed the medical records of patients seen between 1990 and 2020 for the patient demographics, including psychiatric history, clinical findings, diagnostic studies, treatment, and resolution rates.

A total of 6 patients, all female, aged 14 to 60 years of age were identified who had been diagnosed with unilateral psychogenic ptosis. In all cases, the patients had sustained a physical injury before the onset of the ptosis.

Ho pointed out that imaging had been performed for all patients, and none had been diagnosed correctly at referral. The associated signs observed were “concurrent brow ptosis, orbicularis oculi spasm, squint on upgaze, and variable levator function and eyelid margin measurements.”

Four of the 6 patients had preexisting psychological conditions. Patients were managed primarily with reassurance, the investigators reported.

Ho and colleagues concluded, “Psychogenic ptosis is an often delayed or misdiagnosed condition, resulting in unnecessary referrals and imaging. Psychogenic ptosis should be considered in patients with atypical findings of ptosis including ipsilateral brow depression, orbicularis oculi spasm, squint on upgaze, and variable eyelid measurements.”

They also pointed out that a previous minor trauma and female sex were common in their study and that partial/complete resolution can be achieved by reassuring the patients. They recommend that clinicians have a low threshold for psychiatric or psychological evaluation, considering the number of patients with comorbid psychiatric conditions.

Reference
  1. Ho TC, Couch SM, Custer PL. Psychogenic ptosis. Ophthal Plast Reconstr Surg. 2022; published online March 23, 2022; doi: 10.1097/IOP.0000000000002157

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.